Mohammad Amjad Kamal0000-0003-0088-0565
Mohammad A. Kamal is a distinguished Adj. Professor at KFMRC, King Abdulaziz University, Saudi Arabia, where he was a full Professor from March 2011 to March 2013. Professor Kamal’s overall biochemical research output was culminated in more than 145 publications in internationally respected journals. His research was pivotal in supporting the development of the novel anti-Alzheimer agents via collaboration with Dr. Nigel H. Greig (USA). He had migrated to Australia in 1998 and was awarded a prestigious U2000 postdoctoral fellowship in 2000 by the School of Molecular and Microbial Biosciences, University of Sydney. Professor Kamal also collaborated in one of the molecular biological research projects (Type 2 Diabetes and Alzheimer’s Disease) at the UTS. He established his research group, Fundamental and Applied Biology Group, at KFMRC, from March 2011 to Nov 2013. His research aims to focus on advancing the scientific research at KFMRC in providing health translational services to humanity, particularly local Arab community. He is serving in Metabolomics and Enzymology Unit and also as a Regional/Editorial Member/Guest Editor of several reputed journals such as the following on an honorably basis: CNS & ND-DT, Current Drug Metabolism, E-BC & Alternative Medicine, SJBS, Current Psychopharmacology, Mol. & Gen. Med., J. Neurol. Disor., Enzyme Engineering, Recent Patents on Nanomedicine, J. Adv. Health Sci., Med. Chem., Diabetes, Metabolic Syndrome, and Obesity: Targets and Therapy Journal, Am. J. Neuroprotection and Neuroregeneration, Drug Designing, Research J., J. Med. Disorders, Pharmacognosy Magazine, J. Mol. Biol. Techniques, and The Open Biochem. J., Current Aging Science.
Biography Updated on 27 October 2014